Bodycote (LON:BOY – Get Free Report) had its price target reduced by equities research analysts at Deutsche Bank Aktiengesellschaft from GBX 860 to GBX 835 in a research report issued to clients and investors on Tuesday,Digital Look reports. The firm presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 36.55% from the stock’s current price.
A number of other research firms have also issued reports on BOY. Berenberg Bank restated a “buy” rating and set a GBX 800 price objective on shares of Bodycote in a research report on Wednesday, July 30th. Royal Bank Of Canada raised their target price on Bodycote from GBX 650 to GBX 775 and gave the company an “outperform” rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. reduced their price target on shares of Bodycote from GBX 610 to GBX 600 and set a “neutral” rating for the company in a report on Tuesday, October 28th. Finally, Peel Hunt reaffirmed a “buy” rating and issued a GBX 845 price objective on shares of Bodycote in a report on Tuesday. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 771.
Check Out Our Latest Stock Analysis on BOY
Bodycote Stock Performance
About Bodycote
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Further Reading
- Five stocks we like better than Bodycote
- The Role Economic Reports Play in a Successful Investment Strategy
- Down 45% Year-to-Date, Novo Nordisk Ignites a Price War
- How to Find Undervalued Stocks
- Institutions Love These 3 Companies, Should You As Well?
- What Are Dividend Champions? How to Invest in the Champions
- 3 Data Center Stocks Are Soaring—Analysts Think 1 Could Go Higher
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
